Singapore: Australian authorities have just approved a new drugvenetoclax that is touted to have the power to "melt away...
Boehringer Ingelheim announced new data from the Phase I INVICTAN-1 study, which show that BI 695502, its bevacizumab bi...
Singapore: A team of scientists from National University of Singapore (NUS) has established novel insights into the rel...
GlaxoSmithKline and biopharmaceutical company, Innoviva, have concluded Salford Lung Study (SLS), a Phase IIIb multi-cen...
Singapore: Singapore has completed phase I clinical trial of an oral-anti-diabetic drug developed by Department of Pharm...
Singapore: New blockbuster cancer drug from South Korea's Hanmi pharmaceuticals is in troubled waters after a patient di...
Singapore: Waters Corporation recently collaborated with Bioprocessing Technology Institute (BTI), a research institute ...
Singapore: Allen David Roses, a renowned neurologist who pioneered breakthrough research in Alzhiemer's Disease, passed ...
Singapore: With a view to speed up the approval process and improve access to breakthrough drugs, the Australian federal...
Munich: Danish Drug maker Novo Nordisk recently announced that patients treated with Semaglutide, an investigational glu...
TOKYO: Eisai Co., Ltd. announced that its European regional headquarters Eisai Europe Ltd. has received license from the...
Singapore: Researchers in Singapore have developed a new protein that can alter DNA in living cells with much higher pre...
Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food & Drug Administrat...
Singapore: Australian company Novogen, engaged in a pilot program aimed at breakthrough development of drugs to treat a ...
Singapore: Glenmark Pharmaceuticals has started the discovery and initiation of IND enabling studies of a novel clinical...
Singapore: Investigational agent, tivozanib, has demonstrated statistically significant and clinically meaningful PFS su...
Pluristem Therapeutics Inc., Israel's developer of placenta-based cell therapy products, has reached an agreement with J...
Singapore: Australia-based Bone Medical, a biopharmaceutical company focused on the development of new medicines for mus...
